Sriram Subramaniam

3PUBLICATIONS
50CO-AUTHORS
Molecular targetsGene and molecular therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 08, 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements.

Shruti U Gandhy, Sandra J Casak, Sirisha L Mushti

|Apr 06, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Katie Chon, Erin Larkins, Somak Chatterjee

|Dec 05, 2022
FDA Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients with Metastatic Castration-Resistant Prostate Cancer.

Jaleh Fallah, Sundeep Agrawal, Haley Gittleman

Pageof 1